RPTX Repare Therapeutics Inc.

Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded by Daniel Durocher, Agnel Sfeir and Frank Sicheri on September 6, 2016 and is headquartered in Saint-Laurent, Canada.

$23.26  +2.99 (14.75%)
As of 12/07/2021 11:50:36 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/19/2020
Outstanding shares:  41,735,057
Average volume:  184,093
Market cap:   $875,601,496
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    760273102
ISIN:        US7602731025
Sedol:      BLF0CW7
Valuation   (See tab for details)
PE ratio:   -9.01
PB ratio:   3.45
PS ratio:   0.00
Return on equity:   -43.01%
Net income %:   -10,941.84%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy